These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 872497)

  • 1. Digoxin kinetics in patients with thyroid dysfunction.
    Lawrence JR; Sumner DJ; Kalk WJ; Ratcliffe WA; Whiting B; Gray K; Lindsay M
    Clin Pharmacol Ther; 1977 Jul; 22(1):7-13. PubMed ID: 872497
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum digoxin in patients with thyroid disease.
    Croxson MS; Ibbertson HK
    Br Med J; 1975 Sep; 3(5983):566-8. PubMed ID: 1100180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urinary digoxin in thyroid dysfunction.
    Shenfield GM; Thompson J; Horn DB
    Eur J Clin Pharmacol; 1977 Dec; 12(6):437-43. PubMed ID: 598418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE; Spring P; Dettli L
    Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum level of digoxin and digitoxin and glomerular filtration rate in hyper- and hypothyroidism].
    Juhl-Johnsen C; Kokenge F; Kolenda KD
    Dtsch Med Wochenschr; 1983 Mar; 108(10):378-83. PubMed ID: 6825578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease.
    Doherty JE; Perkins WH
    Ann Intern Med; 1966 Mar; 64(3):489-507. PubMed ID: 4159745
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of thyroid disease on the regulation, expression, and function of ABCB1 (MDR1/P glycoprotein) and consequences for the disposition of digoxin.
    Burk O; Brenner SS; Hofmann U; Tegude H; Igel S; Schwab M; Eichelbaum M; Alscher MD
    Clin Pharmacol Ther; 2010 Nov; 88(5):685-94. PubMed ID: 20844484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of digoxin in relation to therapy in the elderly.
    Caird FI
    Gerontol Clin (Basel); 1974; 16(1):68-74. PubMed ID: 4604761
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Kinetics of elimination and dosage of digoxin in patients with kidney failure].
    Risler T
    Dtsch Med Wochenschr; 1974 Oct; 99(42):2130-1. PubMed ID: 4426236
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the pharmacokinetics of digoxin in patients with hyperthyroidism].
    Gilfrich HJ
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1726-8. PubMed ID: 1030093
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacokinetics of digoxin in patients with manifest hyperthyroidism and after normalization of thyroid function.
    Bonelli J; Haydl H; Hruby K; Kaik G
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):302-6. PubMed ID: 669876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and elimination kinetics of digoxin after multiple oral doses.
    Hsieh YY; Huang JD; Lin FL; Chen RR; Lin MS; Hsu KL; Chen JH; Wu TL; Su CT; Hsu JC
    Taiwan Yi Xue Hui Za Zhi; 1983 Dec; 82(12):1269-78. PubMed ID: 6585473
    [No Abstract]   [Full Text] [Related]  

  • 13. Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.
    Sumner DJ; Russell AJ
    Br J Clin Pharmacol; 1976 Apr; 3(2):221-9. PubMed ID: 973956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state kinetics of digoxin in the elderly.
    Roberts MA; Caird FI
    Age Ageing; 1976 Nov; 5(4):214-23. PubMed ID: 1008007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on pharmacokinetics of digoxin in hyperthyroid and hypothyroid dogs].
    Wakamatsu Y; Ogawa K
    Jpn Circ J; 1982 Nov; 46 Suppl 3():501-9. PubMed ID: 7131718
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the metabolism of inorganic iodine in thyroid diseases. Methodological collation and statistical analysis].
    Jaffiol C; Segalas J; Baldet L; Vierne Y
    Ann Endocrinol (Paris); 1970; 31(5):957-61. PubMed ID: 5511413
    [No Abstract]   [Full Text] [Related]  

  • 17. Paracetamol pharmacokinetics in thyroid disease.
    Forfar JC; Pottage A; Toft AD; Irvine WJ; Clements JA; Prescott LF
    Eur J Clin Pharmacol; 1980 Oct; 18(3):269-73. PubMed ID: 7439247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin in the elderly: pharmacokinetic consequences of old age.
    Cusack B; Kelly J; O'Malley K; Noel J; Lavan J; Horgan J
    Clin Pharmacol Ther; 1979 Jun; 25(6):772-6. PubMed ID: 445943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin clearance and glomerular filtration rate.
    Lucchini CR; Padeletti L; Marsilii A; Porciani MC; Bertini G
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):186-8. PubMed ID: 447440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thyroid dysfunction on the metabolism of halothane, enflurane and methoxyflurane in rats.
    Siegers CP; Mackenroth T; Wächter S; Younes M
    Pharmacology; 1981; 22(1):41-6. PubMed ID: 7220596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.